NCT00378248

Ullevål PersonalityProject

Name: Clinical Trial NCT00378248
Creator: Oslo University Hospital
Keywords: Personality Disorders, Combined psychotherapy, behavioral, clinical trial, Norway

Ullevål PersonalityProject. A Randomized Controlled Trial of Intensive Daytreatment Followed by Outpatient Long-term Combined Treatment Compared With Eclectic Individual Therapy for Patients With Personality Disorders

Oslo University Hospital·ClinicalTrials.gov·behavioral

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Personality Disorders
Drug/Device/Intervention: Combined psychotherapy
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Oslo University Hospital
Location: Oslo, Norway

Timeline & enrollment

Phase: N/A
Start date: May 01, 2004
End date: Dec 01, 2016
Enrollment: 120 participants

Primary outcome

Psychosocial functioning,symptom distress,self esteem,interpersonal problems,,self destructive behavior,,personality pathology,,quality of life,,health care utilization after

Summary

Ullevål PersonalityProject is a ranomized controlled trial of treatment of patients with personality disorder. It's main purpose is to test the effect of a long-term combined treatment program compared with eclectic individual therapy for patients with personality disorders.  The main study hypothesis is that long-term combined treatment is superior to eclectic individual therapy with respect to improvement in personality functioning, psychosocial functioning, symptoms, interpersonal problems, and self destructive behavior for poorly functioning patients with personality disorders.

ICD-10 classifications

Specific personality disordersOther specific personality disordersPersonality disorder, unspecifiedDisorders of adult personality and behaviourOther specified disorders of adult personality and behaviour

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT00378248
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT00378248 through Pure Global AI's free database. This phase not specified trial is sponsored by Oslo University Hospital and is currently status unknown. The study focuses on Personality Disorders. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.